top of page
Search

Occuity Partners with Designs for Vision as Exclusive Distributor of PM1 Pachymeter in Australasia
Occuity is pleased to announce our partnership with Designs For Vision, a leading distributor of ophthalmic equipment for over 50 years....
Richard Kadri-Langford
Oct 3, 20232 min read
115 views

Occuity Partners with Laméris as Exclusive Distributor of PM1 Pachymeter
Occuity is pleased to announce our partnership with Laméris, a leading distributor of ophthalmic equipment for over 100 years. Under this...
Richard Kadri-Langford
Sep 25, 20232 min read
62 views

The Future of Myopia Management: Occuity AX1 Axiometer™
Myopia Action Month It's Myopia Action Month, (September 2023) a new global initiative launched this year with a clear objective to...
Richard Kadri-Langford
Sep 19, 20232 min read
94 views

Eyes on the Future: Occuity's Vienna Mission
Accompanied by Mark Jenkins, Occuity's Chief Operating Officer, I packed my bags and, bleary-eyed, headed off out the door. Ahead of us,...
Richard Kadri-Langford
Sep 15, 20232 min read
156 views

Occuity makes FDA 510 (K) mark submission to sell the PM1 in the United States
The submission of the PM1 Pachymeter for FDA 510 (k) approval represents a critical milestone in launching the PM1 in the US market. A...
Richard Kadri-Langford
Sep 15, 20232 min read
91 views

Occuity to Showcase the PM1 and AX1 in Vienna to coincide with the 41st ESCRS Congress!
We are delighted to announce that Mark Jenkins, the Chief Operating Officer of Occuity, and Richard Kadri-Langford, the Head of Digital...
Richard Kadri-Langford
Sep 5, 20232 min read
28 views

Shareholder Update - A view from the front
As some of you may already know, we are committed to attracting exceptional talent to come and work with us and recently appointed...
Richard Kadri-Langford
Jul 11, 20235 min read
144 views

Occuity PM1 Clinical Trial Study Reported in Journal Ophthalmic & Physiological Optics (OPO)
Occuity is excited to announce the publication in the prestigious Journal of Ophthalmic & Physiological Optics (OPO) of the paper on the...
Dan Daly
Jul 3, 20232 min read
179 views

Occuity Named Finalist for Hard Tech Investment of the Year at UK Business Angels Association
We are thrilled to announce that Occuity has been selected as a finalist for the prestigious Hard Tech Investment of the Year award at...
Dan Daly
Jun 14, 20232 min read
80 views

Occuity Recognised as a Top 13 European MedTech Startup to Watch by Sifted (Financial Times)
Occuity Recognized as a Top 13 European MedTech Startup to Watch by Sifted (Financial Times)
Richard Kadri-Langford
Jun 9, 20232 min read
118 views

Monitoring Myopia Progression: Why Axial Length Measurements Are Taking the Lead
A recent article published in The Review of Myopia Management by Thomas Naduvilath, Msc Biostatistics, PhD, the Head of Biostatistics at...
Richard Kadri-Langford
May 22, 20231 min read
59 views

Occuity enters Boehringer Ingelheim start-ups acceleration program Synapse Acceleration®
Occuity enters Boehringer Ingelheim start-ups program Synapse Acceleration®, looking at non-invasive glucose monitoring in veterinary
Dan Daly
Dec 19, 20222 min read
190 views

CooperVision Sign Letter of Intent for AX1 Global Distribution
Occuity is delighted to have received a letter of intent from world-leading contact lens manufacturer CooperVision, Inc, expressing their...
Henry Tsang
Nov 21, 20222 min read
388 views

Tech Start-up of the Year...
The Occuity Team was delighted to win "Tech Start-up of the Year" at The Business Magazine's prestigious Thames Valley Tech Awards 2022...
Richard Kadri-Langford
Oct 21, 20221 min read
234 views

Occuity becomes the largest MedTech raise ever on crowdfunding platform Seedrs, with £2.85m raise.
Occuity have successfully raised over £2.85m from more than 850 investors from over 38 countries, on the leading crowdfunding platform,...
Kim Rasmussen
Nov 1, 20213 min read
265 views

Crowdfunding Closes 10 pm Tonight
Please note our Seedrs crowdfunding round has now closed. However, if you are still interested in investing please contact us here Hello...
Richard Kadri-Langford
Oct 4, 20211 min read
116 views

Longevitytech.fund make significant investment in Occuity
Whilst our crowdfunding campaign on Seedrs continues to overfund, we are also in discussion with several angel investors and investment...
kimrasmussen5
Sep 27, 20212 min read
169 views

An Interview with Optometry Today
The launch of our crowdfunding round has generated a great deal of interest. We featured in a number of business publications, which have...
Richard Kadri-Langford
Sep 8, 20211 min read
65 views

Gavin Sandison is a diabetic AND investor in Occuity...
No energy, depressed, bedridden... ….But otherwise ‘fit & healthy’ and only 25 years of age! Gavin Sandison's childhood and adolescence...
Richard Kadri-Langford
Sep 8, 20211 min read
66 views

We are now Overfunding!
Just a day after our public launch on Seedrs, we’re delighted to announce that we have already hit our funding target. It’s a great...
Monica Giudice
Aug 25, 20212 min read
66 views
bottom of page